Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Non Operating Income: 2019-2021

Historic Non Operating Income for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to -$375,000.

  • Black Diamond Therapeutics' Non Operating Income fell 167.32% to -$375,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.0 million, marking a year-over-year decrease of 189.79%. This contributed to the annual value of -$2.2 million for FY2021, which is 194.47% down from last year.
  • Black Diamond Therapeutics' Non Operating Income amounted to -$375,000 in Q4 2021, which was up 23.31% from -$489,000 recorded in Q3 2021.
  • Over the past 5 years, Black Diamond Therapeutics' Non Operating Income peaked at $734,000 during Q2 2020, and registered a low of -$1.1 million during Q3 2019.
  • Over the past 3 years, Black Diamond Therapeutics' median Non Operating Income value was -$375,000 (recorded in 2021), while the average stood at -$171,667.
  • Its Non Operating Income has fluctuated over the past 5 years, first soared by 5,546.15% in 2020, then crashed by 200.82% in 2021.
  • Over the past 3 years, Black Diamond Therapeutics' Non Operating Income (Quarterly) stood at $469,000 in 2019, then rose by 18.76% to $557,000 in 2020, then slumped by 167.32% to -$375,000 in 2021.
  • Its Non Operating Income was -$375,000 in Q4 2021, compared to -$489,000 in Q3 2021 and -$740,000 in Q2 2021.